logo-loader

Wize Pharma Inc shows it's LO2A Eye Drops, which treat Dry Eye syndrome

Published: 16:48 04 Jun 2019 EDT

Wize Pharma Inc (OTCMKTS:WIZP) Chairman Noam Danenberg joins Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. Wize Pharma is a clinical-stage biopharmaceutical company. The Israeli company is focused on the treatment of ophthalmic disorders.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 22 minutes ago